Metraipolis › archive › dc_beb2e489a132
What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis — Europe PMC PMID:42524056
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42524056
- DOI
- 10.3389/fimmu.2026.1854279
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:17:47.893Z
- SHA-256 of the archived text
8129ce9d63ff1e8f65327acb3f0f19c0f5d0a0298aa472caf4ade3d64fa3200f- Stable URL of this page
https://metraipolis.com/documento/dc_beb2e489a132
How to cite
What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis — Europe PMC PMID:42524056 — Europe PMC (en), https://europepmc.org/article/MED/42524056 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beb2e489a132 (Metraipolis archive dc_beb2e489a132, sha256 8129ce9d63ff1e8f65327acb3f0f19c0f5d0a0298aa472caf4ade3d64fa3200f)
BibTeX
@misc{dcbeb2e489a132,
title = {What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis — Europe PMC PMID:42524056},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42524056},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beb2e489a132; sha256 8129ce9d63ff1e8f65327acb3f0f19c0f5d0a0298aa472caf4ade3d64fa3200f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42524056. Agents can read the archived copy with the MCP tool read_document.